{
    "2018-04-13": [
        [
            {
                "time": "",
                "original_text": "[买入评级]云南白药(000538)年报点评：高管激励优化有望激发发展潜力",
                "features": {
                    "keywords": [
                        "云南白药",
                        "年报",
                        "高管激励",
                        "发展潜力"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "云南白药:业绩符合预期,期待二次腾飞",
                "features": {
                    "keywords": [
                        "云南白药",
                        "业绩",
                        "预期",
                        "二次腾飞"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}